Type III interferons suppress influenza A virus infection independently of STAT activation by triggering cell death

Wiktor Prus,Frederic Grabowski,Paulina Koza,Zbigniew Korwek,Maciej Czerkies,Marek Kochańczyk,Tomasz Lipniacki

DOI: https://doi.org/10.1101/2024.09.09.612051

2024-10-06

Abstract:Type III interferons (IFN-λ1–λ4) are known to limit influenza virus infections in vivo and are non-redundant to type I interferons (IFN-α and IFN-β). Here, we demonstrated in vitro that type III interferons limit infection with influenza A virus (IAV) independently of STAT1 and STAT2 activation. Despite the fact that the knockout of the IFN-λ receptor (subunit IFNLR1), compared to the knockout of the IFN-β receptor (subunit IFNAR1), is associated with higher levels of STAT1/2 phosphorylation during infection, it results in a greater proportion of IAV-infected cells and higher viral RNA and protein levels. We showed that the ratio of dying to infected cells is lower in IFNLR1-deficient cells compared to wild-type cells suggesting that type III interferons limit the spread of IAV by promoting the death of IAV-infected cells. In contrast, type I interferons induce a stronger accumulation of proteins coded by interferon-stimulated genes, and correspondingly suppress IAV spread more effectively than type III interferons when provided prior to infection. Overall, our results suggest an additional non-transcriptional role of type III interferons in the control of viral infections.

Immunology

What problem does this paper attempt to address?

The main problem this paper attempts to address is the mechanism by which type III interferon (IFN-λ) inhibits influenza A virus (IAV) infection, specifically whether it acts independently of the STAT signaling pathway. Through experiments, researchers found that IFN-λ can limit the spread of IAV by promoting the death of infected cells, a process that does not rely on the activation of STAT1 and STAT2. Additionally, compared to type I interferon (such as IFN-β), IFN-λ exhibits significant differences in its mechanism of inhibiting IAV spread. Although both can induce an antiviral state, IFN-λ is more effective in promoting cell death under certain conditions, thereby reducing viral dissemination.

Specifically, the study explores this issue through the following points:
1. **Comparison of IFN-λ and IFN-β**: Researchers compared the effects of IFN-λ and IFN-β in activating the STAT signaling pathway and inducing the expression of interferon-stimulated genes (ISGs), finding that IFN-β is more effective in these aspects.
2. **Impact of IFNLR1 knockout cells**: By using IFNLR1 knockout cells (lacking the IFN-λ receptor subunit), researchers observed a significant increase in IAV infection rates and viral RNA levels in these cells, while the phosphorylation levels of STAT1/2 did not change much. This suggests that IFN-λ may inhibit IAV spread through non-transcriptional mechanisms, such as promoting cell death.
3. **Measurement of cell death rates**: Researchers used mathematical models and experimental data to demonstrate that IFN-λ signaling can increase the death rate of IAV-infected cells, thereby reducing viral spread.

Overall, this paper reveals the unique role of IFN-λ in controlling IAV infection, particularly in promoting the death of infected cells. This finding contributes to a deeper understanding of the complex mechanisms of interferon in antiviral immunity.